The MD Magazine Endocrinology specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Latest Headlines

FDA Warning: Disabling Joint Pain Seen in Diabetes Drugs
The US Food and Drug administration today issued a warning that the type 2 diabetes medicines sitagliptin (Januvia/Merck) linagliptin (Tradjenta/BI), and alogliptin (Nesina/Takeda) “may cause joint pain that can be severe and disabling.”
A systematic review of alopecia areata (AA) in Clinical, Cosmetic & Investigational Dermatology highlighted the unpredictability and lack of treatment options for the condition. But it also pointed to a larger problem: more than half of patients with AA experience poor health-related quality of life (QOL). Patients with AA are at risk for depression and anxiety, atopy, vitiligo, thyroid disease, and other autoimmune conditions.
It is unclear how many people have pituitary incidentaloma, but imaging and autopsy studies indicate they are quite common and occur in up to one-third of patients. Fortunately, the vast majority of these serendipitously discovered tumors are clinically insignificant. A management guideline in the Annals of Endocrinology brings endocrinologists up to date on current thinking about pituitary incidentaloma management.
Most self-improvement intervention programs rely on self-monitoring, or increased awareness of bad habits, to help people change their behaviors. Traditionally, programs have used diaries, calendar notes, or check-ins at daily or weekly meetings to help individuals recognize and replace unhelpful routines. The October 2015 issue of Telemedicine and e-Health includes a study that describes how simple electronic feedback can help people with weight problems.
New research concludes that the association between celiac disease and exocrine pancreatic insufficiency (EPI) is strong enough that physicians should check for EPI when celiac patients suffer malnutrition or gastric distress despite adherence to prescribed diets.
Patients with the cystic fibrosis transmembrane conductance regulator gating mutation G551D have insufficient ion transport due to reduced channel-open probability. New information suggests that increased ion transport reduces disease burden in the pancreas, which prevents cystic fibrosis patients from digesting food properly and leads to exocrine pancreatic insufficiency in up to 90% of all cases.

Most Popular in Endocrinology

Recent Published Journal

$vacMongoViewPlus$ $vAR$